Johnson & Johnson Announces Kristen Mulholland as New CHRO, Succeeding Dr. Peter M. Fasolo

Johnson & Johnson has announced that Dr. Peter M. Fasolo, Executive Vice President and Chief Human Resources Officer, will retire at the end of this year after 16 years of service and leadership at the company and has promoted Kristen Mulholland to take over his role.

Mulholland has been Head of Human Resources, Global Total Rewards at Johnson & Johnson since 2019. In this role, she has successfully managed compensation, benefits, global health services, acquisitions, and divestitures for nearly five years. She has also been a part of the Human Resources Executive Leadership Team, overseeing a group of 400+ HR leaders.

Joaquin Duato, Chairman and Chief Executive Officer, of Johnson & Johnson, said, "I’m pleased to appoint Kristen to this important role where she will apply her deep business acumen, talent expertise and Credo-based approach to advance J&J’s culture and operating model. I’m confident her breadth of experience and strong leadership will ensure Johnson & Johnson’s human capital strategy is poised to deliver the innovative future-ready talent and culture needed to advance healthcare solutions for patients worldwide.”

Brief About Kristen Mulholland’s Career   

Mulholland began her career at Ernst & Young as a manager in Cleveland, Ohio, from 1989 to 1999. She then spent six years as Director of Human Resources at Eli Lilly in Indianapolis. In 2005, she joined Johnson & Johnson as Director of Human Resources in Cincinnati, focusing on U.S. medical devices. She later moved to Ethicon Endo-Surgery as VP of Human Resources for Global Medical Devices, then returned to Johnson & Johnson in 2011 as VP of Global Performance Management and Development. In 2012, she joined Janssen Pharmaceutical Companies as VP of Human Resources for R&D and Innovation Centers, later becoming Head of Human Resources for Pharmaceuticals and External Innovation. She rejoined Johnson & Johnson in October 2019 as Head of Human Resources, Global Total Rewards.

Kristen Mulholland, a seasoned leader with significant experience across Johnson & Johnson’s Innovative Medicine and MedTech sectors, will join Johnson & Johnson’s Executive Committee on October 1, 2024, and will work closely with Dr. Fasolo during a transition period before his retirement.